FDA Clearance Tracker · K260578
Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)
Last checked: Nov 20, 2026Latest source record: Jul 14, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jul 14, 2026
Substantially Equivalent
Time to decision
144 days
Received Feb 20, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K260578
- Device name
- Ambu® NeurolineTM Cup MRI/CT (Models 72704/21US, 72704/23US, 72704/25US, 72704/27US) Ambu® NeurolineTM Cup MRI/CT-set (Models 72704/21-1010US, 72704/21-1010US, 72704/23-1010US, 72704/25-1010US, 72704/27-1010US) Ambu® NeurolineTM Cup MRI/CT-mini set (Models 72704/21-0301US, 72704/23-0301US, 72704/25-0301US, 72704/27-0301US)
- Applicant
- Ambu A/S
- Applicant location
- Ballerup, DK
- Received
- Feb 20, 2026
- Decided
- Jul 14, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Electrode, Cutaneous (GXY)
- Device class
- Class II
- Regulation
- 21 CFR 882.1320
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GXY. The earliest in FDA's data is K760312, decided Aug 4, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260578
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Ambu A/S
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260309 · Decided Sep 16, 2026 · 229 days after receipt
Device type: Bronchoscope (Flexible Or Rigid) (EOQ) · Otolaryngology (ENT)
K261400 · Decided Sep 16, 2026 · 140 days after receipt
Device type: Gastroscope And Accessories, Flexible/Rigid (FDS) · GI, Urology & Nephrology
K251583 · Decided Apr 30, 2026 · 342 days after receipt
Device type: Filter, Bacterial, Breathing-Circuit (CAH) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.